EA201990729A1 - BIOMARKERS-METABOLITES FOR DISEASES ASSOCIATED WITH A CONTACT ACTIVATION SYSTEM - Google Patents

BIOMARKERS-METABOLITES FOR DISEASES ASSOCIATED WITH A CONTACT ACTIVATION SYSTEM

Info

Publication number
EA201990729A1
EA201990729A1 EA201990729A EA201990729A EA201990729A1 EA 201990729 A1 EA201990729 A1 EA 201990729A1 EA 201990729 A EA201990729 A EA 201990729A EA 201990729 A EA201990729 A EA 201990729A EA 201990729 A1 EA201990729 A1 EA 201990729A1
Authority
EA
Eurasian Patent Office
Prior art keywords
activation system
biomarkers
metabolites
contact activation
diseases associated
Prior art date
Application number
EA201990729A
Other languages
Russian (ru)
Inventor
Дэниел Дж. Секстон
Малини Висванатан
Райан Фосетт
Трипти Гаур
Original Assignee
Дайэкс Корп.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дайэкс Корп. filed Critical Дайэкс Корп.
Priority claimed from PCT/US2017/051755 external-priority patent/WO2018053247A1/en
Publication of EA201990729A1 publication Critical patent/EA201990729A1/en

Links

Abstract

Настоящее изобретение относится к способам и наборам для анализа биологического образца, полученного из индивидуума, имеющего, как предполагают, имеющего заболевание или имеющего риск развития заболевания, ассоциированного с контактной системой активации.The present invention relates to methods and kits for analyzing a biological sample obtained from an individual who is believed to have a disease or has a risk of developing a disease associated with a contact activation system.

EA201990729A 2017-06-12 2017-09-15 BIOMARKERS-METABOLITES FOR DISEASES ASSOCIATED WITH A CONTACT ACTIVATION SYSTEM EA201990729A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762518367P 2017-06-12 2017-06-12
PCT/US2017/051755 WO2018053247A1 (en) 2016-09-16 2017-09-15 Metabolite biomarkers for diseases associated with the contact activation system

Publications (1)

Publication Number Publication Date
EA201990729A1 true EA201990729A1 (en) 2019-08-30

Family

ID=67734919

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990729A EA201990729A1 (en) 2017-06-12 2017-09-15 BIOMARKERS-METABOLITES FOR DISEASES ASSOCIATED WITH A CONTACT ACTIVATION SYSTEM

Country Status (1)

Country Link
EA (1) EA201990729A1 (en)

Similar Documents

Publication Publication Date Title
EA201792497A1 (en) ANTIBODIES TO GITR FOR DIAGNOSIS OF MALIGNANT TUMOR
MA52003A (en) TREATMENT METHODS FOR DISEASES ASSOCIATED WITH HPV
DOP2020000245A (en) IL-11 ANTIBODIES
EA201990778A1 (en) ANTI-IL-33 ANTIBODIES AND THEIR APPLICATION
EA201792642A1 (en) DIAGNOSTIC METHODS FOR T-CELL THERAPY
EA201990730A1 (en) RNA BIOMARKERS FOR HEREDITARY ANGIONEUROTIC Edema
MX2020001193A (en) Methods for determining dpp3 and therapeutic methods.
MX2019002918A (en) Metabolite biomarkers for diseases associated with the contact activation system.
EA201690213A1 (en) COMPOSITIONS AND METHOD FOR TREATMENT OF CONNECTED STATES
EA201992026A1 (en) APPLICATION OF BIOMARKERS IN THE IDENTIFICATION OF PATIENTS WHO CANCER WHICH WILL BE CHARACTERIZED BY THE PRESENCE OF TREATMENT WITH PRMT5 INHIBITOR
EA201790769A1 (en) DETERMINATION OF THE LEVELS OF GLYCOSAMINOGLICANES BY THE MASS SPECTROMETRY METHOD
BR112016018205A2 (en) Alzheimer's treatment methods
EA201790211A1 (en) METHOD FOR PREDICTING THE RESULTS OF THE TREATMENT OF AFLIBERCEPT PATIENTS PREFERREDLY SUFFERING FROM CANCER
EA201890340A1 (en) MONOCLONAL ANTIBODY-INHIBITOR OF FACTOR XIIA
EA201892716A1 (en) Antibody to Coagulation Factor XI
MX2020000186A (en) Assays for assessing neutralizing antibodies levels in subjects treated with a biological drug and uses thereof in personalized medicine.
PE20220004A1 (en) SPECIFIC MONOCLONAL ANTIBODIES TO ANTIGEN P OF HUMAN RESPIRATORY SYNCYTIAL VIRUS (HSRV), PRODUCED AND SECRETED BY CELLULAR HYBRIDOMAS, USEFUL FOR THE DETECTION AND DIAGNOSIS OF INFECTION CAUSED BY HRSV
MX2018001697A (en) Method for the quantification of faecalibacterium prausnitzii phylogroup i and/or phylogroup ii members and the use thereof as biomarkers.
BR112019024661A2 (en) ISOLATION OF CIRCULATING EPITHELIAL CELLS IN THE PERIPHERAL BLOOD
NZ729773A (en) Biomarkers for disease progression in melanoma
EA202191666A1 (en) ANTIBODIES TO IL-27 AND THEIR USE
CO2019002599A2 (en) Protein biomarkers for diseases associated with the contact activation system
RU2014113841A (en) METHOD FOR EARLY DIAGNOSTICS OF ENDOGENOUS INTOXICATION
EA201990729A1 (en) BIOMARKERS-METABOLITES FOR DISEASES ASSOCIATED WITH A CONTACT ACTIVATION SYSTEM
CO2019002550A2 (en) Anti-gm-csf antibodies and uses thereof